Aptose Biosciences Inc.

Recent News View All News

Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial

Jan 9, 2025 4:00pm EST

Aptose Announces Positive Decision by Nasdaq Hearings Panel

Dec 19, 2024 4:05pm EST

Upcoming Events View IR Calendar

Annual and Special Meeting of Shareholders

Jan 27, 2025 • 7:00 am PST

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings